EFFICACY AND SAFETY OF ELECTIVE SWITCHING OF INFLAMMATORY BOWEL DISEASE PATIENTS FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB: A MULTI-CENTRE COHORT STUDY
Philip Smith 1
Daniel Storey 1
Belle Gregg 1
Lisa Critchley 1
June Stenson 1
Andrew Kneebone 1
Tracy Rimmer 1
Stevena Burke 1
Shamas Hussain 1
Wan Yi Teoh 2
Stephan Vazille 2
Solange Serna 3
Ashley Bond 1
Alan Steel 1
Martyn Dibb 1
Paul Collins 1
Edmund Derbyshire 1
Keith Bodger 1
Chris Probert 2
Ajay Verma 3
Sree Subramanian 1
1 Liverpool University Hospital NHS Foundation Trust, Liverpool, United Kingdom
2 University of Liverpool, Liverpool, United Kingdom
3 Kettering General Hospital, Kettering, United Kingdom
Topic
IBD
Session
IBD drug efficacy and safety
Conference
UEG Week Virtual 2021
Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]